Cancer Drugs; Etodolac enhanced carboplatin-induced apoptosis of human tongue carcinoma
Cancer Drugs; Etodolac enhanced carboplatin-induced apoptosis of human tongue carcinoma
About this item
Full title
Cancer Drugs; Etodolac enhanced carboplatin-induced apoptosis of human tongue carcinoma
Publisher
Atlanta: NewsRx
Journal title
Science Letter, 2005, p.297
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
The researchers concluded, "In combination with CBDCA, etodolac significantly decreased FAP-1 expression both at protein and mRNA levels, although etodolac by itself did not inhibit FAP-1 expression. These results indicate that etodolac, when combined with CBDCA, can enhance an action of anticancer drug through the suppression of FAP-1 expression."
Alternative Titles
Full title
Cancer Drugs; Etodolac enhanced carboplatin-induced apoptosis of human tongue carcinoma
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_209238288
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_209238288
Other Identifiers
ISSN
1538-9111
E-ISSN
1538-9162
How to access this item
Log in as a Library member
